Congenital complete heart block

Area of Science:

• Pediatric Cardiology
• Immunology
• Neonatology

Background:

• Congenital complete heart block (CCHB) is a serious condition affecting infants.
• Maternal immunologic abnormalities have been increasingly associated with CCHB.
• Early identification and management are crucial for infant survival and quality of life.

Purpose of the Study:

• To highlight the association between maternal immune system dysfunction and CCHB in newborns.
• To emphasize the importance of recognizing clinical signs suggestive of CCHB.
• To outline current therapeutic strategies, including pacemaker implantation, for affected infants.

Main Methods:

• Review of recent studies on CCHB pathogenesis.
• Clinical observation of infants diagnosed with CCHB.
• Analysis of diagnostic criteria and treatment guidelines for CCHB.

Main Results:

• Immunologic abnormalities in mothers are a significant finding in CCHB cases.
• A slow heart rate (bradycardia) before or after birth is a primary indicator of CCHB.
• The atrioventricular (AV) node is the most common site of heart block in CCHB.

Conclusions:

• Suspecting CCHB in infants with bradycardia is essential for timely diagnosis.
• Pacemaker therapy is indicated in specific cases, significantly improving prognosis.
• Infants surviving infancy with CCHB can often achieve relatively normal lives with appropriate management.